Aller au contenu
MediHelp
MediHelp Référence médicamenteuse

Interactions médicamenteuses

Abrocitinib + Eptifibatide

Gravité: Majeure

Abrocitinib and Eptifibatide: major interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Abrocitinib can reduce platelet counts in early treatment and labeling advises against antiplatelet drugs except low-dose aspirin for the first 3 months. Eptifibatide adds potent platelet inhibition, increasing bleeding risk.

Ce que signifie cette interaction, en termes simples

Abrocitinib and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Abrocitinib belongs to Miscellaneous; Eptifibatide belongs to Cardiovascular.

Niveau de preuve: Moderate

Pourquoi elle survient

Additive bleeding risk from GP IIb/IIIa blockade and abrocitinib-associated reduction in platelet count.

Conduite à tenir

Avoid starting abrocitinib in patients needing eptifibatide during the first 3 months. If unavoidable, monitor platelet counts and bleeding.

Questions à poser à votre pharmacien

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Abrocitinib et Eptifibatide, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription
Créer un compte gratuit Se connecter

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Abrocitinib with Eptifibatide?

MediHelp rates the interaction as major. Abrocitinib and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Abrocitinib can reduce platelet counts in early treatment and labeling advises against antiplatelet drugs except low-dose aspirin for the first 3 months. Eptifibatide adds potent platelet inhibition, increasing bleeding risk.

How serious is the interaction between Abrocitinib and Eptifibatide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting abrocitinib in patients needing eptifibatide during the first 3 months. If unavoidable, monitor platelet counts and bleeding.

What other medicines interact with Eptifibatide?

MediHelp also lists interactions of Eptifibatide with, for example, Acalabrutinib, Acetylsalicylic acid, Antithrombin alfa. The full list is on the Eptifibatide page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Télécharger surApp Store Disponible surGoogle Play

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter